Forte Biosciences Inc

Research Forte Biosciences Inc (FBRX) on Bullrun: market cap USD 436.61M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerFBRX
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 436.61M
• Financial periodFY2025
• Net income-USD 69.38M
• Free cash flow-USD 51.00M

Valuation Snapshot

latest market cap is USD 436.61M.

About Forte Biosciences Inc

Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. The company's lead product candidate is the FB-102, a proprietary anti-CD122 monoclonal antibody therapeutic candidate for various autoimmune and autoimmune-related indications, such as celiac disease, vitiligo, alopecia areata, and type 1 diabetes. Forte Biosciences, Inc. is headquartered in Dallas, Texas.

Frequently asked questions

What is Forte Biosciences Inc's market cap?

Forte Biosciences Inc's market capitalization is USD 436.61M.

What does Forte Biosciences Inc do?

Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. The company's lead product candidate is the FB-102, a proprietary anti-CD122 monoclonal antibody therapeutic candidate for various autoimmune and autoimmune-related indications, such as celiac...